Cargando…

Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002

BACKGROUND: Bloodstream infections are associated with significant patient morbidity and mortality. Antimicrobial susceptibility patterns should guide the choice of empiric antimicrobial regimens for patients with bacteremia. METHODS: From January to December of 2002, 82,569 bacterial blood culture...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlowsky, James A, Jones, Mark E, Draghi, Deborah C, Thornsberry, Clyde, Sahm, Daniel F, Volturo, Gregory A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420484/
https://www.ncbi.nlm.nih.gov/pubmed/15134581
http://dx.doi.org/10.1186/1476-0711-3-7
_version_ 1782121482469507072
author Karlowsky, James A
Jones, Mark E
Draghi, Deborah C
Thornsberry, Clyde
Sahm, Daniel F
Volturo, Gregory A
author_facet Karlowsky, James A
Jones, Mark E
Draghi, Deborah C
Thornsberry, Clyde
Sahm, Daniel F
Volturo, Gregory A
author_sort Karlowsky, James A
collection PubMed
description BACKGROUND: Bloodstream infections are associated with significant patient morbidity and mortality. Antimicrobial susceptibility patterns should guide the choice of empiric antimicrobial regimens for patients with bacteremia. METHODS: From January to December of 2002, 82,569 bacterial blood culture isolates were reported to The Surveillance Network (TSN) Database-USA by 268 laboratories. Susceptibility to relevant antibiotic compounds was analyzed using National Committee for Clinical Laboratory Standards guidelines. RESULTS: Coagulase-negative staphylococci (42.0%), Staphylococcus aureus (16.5%), Enterococcus faecalis (8.3%), Escherichia coli (7.2%), Klebsiella pneumoniae (3.6%), and Enterococcus faecium (3.5%) were the most frequently isolated bacteria from blood cultures, collectively accounting for >80% of isolates. In vitro susceptibility to expanded-spectrum β-lactams such as ceftriaxone were high for oxacillin-susceptible coagulase-negative staphylococci (98.7%), oxacillin-susceptible S. aureus (99.8%), E. coli (97.3%), K. pneumoniae (93.3%), and Streptococcus pneumoniae (97.2%). Susceptibilities to fluoroquinolones were variable for K. pneumoniae (90.3–91.4%), E. coli (86.0–86.7%), oxacillin-susceptible S. aureus (84.0–89.4%), oxacillin-susceptible coagulase-negative staphylococci (72.7–82.7%), E. faecalis (52.1%), and E. faecium (11.3%). Combinations of antimicrobials are often prescribed as empiric therapy for bacteremia. Susceptibilities of all blood culture isolates to one or both agents in combinations of ceftriaxone, ceftazdime, cefepime, piperacillin-tazobactam or ciprofloxacin plus gentamicin were consistent (range, 74.8–76.3%) but lower than similar β-lactam or ciprofloxacin combinations with vancomycin (range, 93.5–96.6%). CONCLUSION: Ongoing surveillance for antimicrobial susceptibility remains essential, and will enhance efforts to identify resistance and attempt to limit its spread.
format Text
id pubmed-420484
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-4204842004-06-11 Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002 Karlowsky, James A Jones, Mark E Draghi, Deborah C Thornsberry, Clyde Sahm, Daniel F Volturo, Gregory A Ann Clin Microbiol Antimicrob Research BACKGROUND: Bloodstream infections are associated with significant patient morbidity and mortality. Antimicrobial susceptibility patterns should guide the choice of empiric antimicrobial regimens for patients with bacteremia. METHODS: From January to December of 2002, 82,569 bacterial blood culture isolates were reported to The Surveillance Network (TSN) Database-USA by 268 laboratories. Susceptibility to relevant antibiotic compounds was analyzed using National Committee for Clinical Laboratory Standards guidelines. RESULTS: Coagulase-negative staphylococci (42.0%), Staphylococcus aureus (16.5%), Enterococcus faecalis (8.3%), Escherichia coli (7.2%), Klebsiella pneumoniae (3.6%), and Enterococcus faecium (3.5%) were the most frequently isolated bacteria from blood cultures, collectively accounting for >80% of isolates. In vitro susceptibility to expanded-spectrum β-lactams such as ceftriaxone were high for oxacillin-susceptible coagulase-negative staphylococci (98.7%), oxacillin-susceptible S. aureus (99.8%), E. coli (97.3%), K. pneumoniae (93.3%), and Streptococcus pneumoniae (97.2%). Susceptibilities to fluoroquinolones were variable for K. pneumoniae (90.3–91.4%), E. coli (86.0–86.7%), oxacillin-susceptible S. aureus (84.0–89.4%), oxacillin-susceptible coagulase-negative staphylococci (72.7–82.7%), E. faecalis (52.1%), and E. faecium (11.3%). Combinations of antimicrobials are often prescribed as empiric therapy for bacteremia. Susceptibilities of all blood culture isolates to one or both agents in combinations of ceftriaxone, ceftazdime, cefepime, piperacillin-tazobactam or ciprofloxacin plus gentamicin were consistent (range, 74.8–76.3%) but lower than similar β-lactam or ciprofloxacin combinations with vancomycin (range, 93.5–96.6%). CONCLUSION: Ongoing surveillance for antimicrobial susceptibility remains essential, and will enhance efforts to identify resistance and attempt to limit its spread. BioMed Central 2004-05-10 /pmc/articles/PMC420484/ /pubmed/15134581 http://dx.doi.org/10.1186/1476-0711-3-7 Text en Copyright © 2004 Karlowsky et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research
Karlowsky, James A
Jones, Mark E
Draghi, Deborah C
Thornsberry, Clyde
Sahm, Daniel F
Volturo, Gregory A
Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
title Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
title_full Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
title_fullStr Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
title_full_unstemmed Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
title_short Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
title_sort prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the united states in 2002
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420484/
https://www.ncbi.nlm.nih.gov/pubmed/15134581
http://dx.doi.org/10.1186/1476-0711-3-7
work_keys_str_mv AT karlowskyjamesa prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002
AT jonesmarke prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002
AT draghideborahc prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002
AT thornsberryclyde prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002
AT sahmdanielf prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002
AT volturogregorya prevalenceandantimicrobialsusceptibilitiesofbacteriaisolatedfrombloodculturesofhospitalizedpatientsintheunitedstatesin2002